{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:53:52Z","timestamp":1760622832347},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2466-11-56","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T22:06:43Z","timestamp":1322863603000},"source":"Crossref","is-referenced-by-count":16,"title":["Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy"],"prefix":"10.1186","volume":"11","author":[{"given":"Lars","family":"Knudsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Schurawlew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Tiede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein A","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrike","family":"Wilkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Ewert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Halank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Klose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"B\u00e4zner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Behr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius M","family":"Hoeper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,1]]},"reference":[{"issue":"5","key":"288_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"R Barst","year":"1996","unstructured":"Barst R, Rubin L, Long W, McGoon M, Rich S, Badesch D, Groves B, Tapson V, Bourge R, Brundage B: A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996, 334 (5): 296-302. 10.1056\/NEJM199602013340504.","journal-title":"N Engl J Med"},{"issue":"12","key":"288_CR2","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1164\/rccm.200505-766OC","volume":"172","author":"M Gomberg-Maitland","year":"2005","unstructured":"Gomberg-Maitland M, Tapson VF, Benza RL, McLaughlin VV, Krichman A, Widlitz AC, Barst RJ: Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Am J Respir Crit Care Med. 2005, 172 (12): 1586-1589. 10.1164\/rccm.200505-766OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"288_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1183\/09031936.00130408","volume":"34","author":"M Hoeper","year":"2009","unstructured":"Hoeper M, Gall H, Seyfarth H, Halank M, Ghofrani H, Winkler J, Golpon H, Olsson K, Nickel N, Opitz C, Ewert R: Long-term outcome with intravenous iloprost in pulmonary arterial hypertension. Eur Respir J. 2009, 34 (1): 132-137. 10.1183\/09031936.00130408.","journal-title":"Eur Respir J"},{"issue":"4","key":"288_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00392-007-0490-3","volume":"96","author":"R Ewert","year":"2007","unstructured":"Ewert R, Opitz C, Wensel R, Winkler J, Halank M, Felix S: Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension. Clin Res Cardiol. 2007, 96 (4): 211-217. 10.1007\/s00392-007-0490-3.","journal-title":"Clin Res Cardiol"},{"key":"288_CR5","volume-title":"Respir Med","author":"Z Safdar","year":"2011","unstructured":"Safdar Z: Treatment of pulmonary arterial hypertension: The role of prostacyclin and prostaglandin analogs. Respir Med. 2011"},{"issue":"2","key":"288_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1183\/09031936.00078207","volume":"31","author":"J Dupuis","year":"2008","unstructured":"Dupuis J, Hoeper M: Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J. 2008, 31 (2): 407-415. 10.1183\/09031936.00078207.","journal-title":"Eur Respir J"},{"issue":"1","key":"288_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1183\/09031936.00124007","volume":"32","author":"M Wilkins","year":"2008","unstructured":"Wilkins M, Wharton J, Grimminger F, Ghofrani H: Phosphodiesterase inhibitors for the treatment of pulmonary hypertension. Eur Respir J. 2008, 32 (1): 198-209. 10.1183\/09031936.00124007.","journal-title":"Eur Respir J"},{"issue":"4","key":"288_CR8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1183\/09031936.00097107","volume":"31","author":"M Gomberg-Maitland","year":"2008","unstructured":"Gomberg-Maitland M, Olschewski H: Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J. 2008, 31 (4): 891-901. 10.1183\/09031936.00097107.","journal-title":"Eur Respir J"},{"issue":"2","key":"288_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.rmed.2006.05.019","volume":"101","author":"F Reichenberger","year":"2007","unstructured":"Reichenberger F, Mainwood A, Doughty N, Fineberg A, Morrell NW, Pepke-Zaba J: Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension. Respir Med. 2007, 101 (2): 217-222. 10.1016\/j.rmed.2006.05.019.","journal-title":"Respir Med"},{"issue":"5","key":"288_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.rmed.2010.01.008","volume":"104","author":"H Olschewski","year":"2010","unstructured":"Olschewski H, Hoeper MM, Behr J, Ewert R, Meyer A, Borst MM, Winkler J, Pfeifer M, Wilkens H, Ghofrani HA, Nikkho S, Seeger W: Long-term therapy with inhaled iloprost in patients with pulmonary hypertension. Respir Med. 2010, 104 (5): 731-740. 10.1016\/j.rmed.2010.01.008.","journal-title":"Respir Med"},{"issue":"6","key":"288_CR11","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1183\/09031936.00139009","volume":"34","author":"N Gali\u00e8","year":"2009","unstructured":"Gali\u00e8 N, Hoeper M, Humbert M, Torbicki A, Vachiery J, Barbera J, Beghetti M, Corris P, Gaine S, Gibbs J, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G: Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009, 34 (6): 1219-1263.","journal-title":"Eur Respir J"},{"issue":"5","key":"288_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","volume":"115","author":"G D'Alonzo","year":"1991","unstructured":"D'Alonzo G, Barst R, Ayres S, Bergofsky E, Brundage B, Detre K, Fishman A, Goldring R, Groves B, Kernis J: Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991, 115 (5): 343-349.","journal-title":"Ann Intern Med"},{"issue":"4","key":"288_CR13","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1161\/01.CIR.89.4.1733","volume":"89","author":"J Sandoval","year":"1994","unstructured":"Sandoval J, Bauerle O, Palomar A, G\u00f3mez A, Mart\u00ednez-Guerra M, Beltr\u00e1n M, Guerrero M: Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation. 1994, 89 (4): 1733-1744.","journal-title":"Circulation"},{"issue":"4","key":"288_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","volume":"40","author":"O Sitbon","year":"2002","unstructured":"Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herv\u00e9 P, Rainisio M, Simonneau G: Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol. 2002, 40 (4): 780-788. 10.1016\/S0735-1097(02)02012-0.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"288_CR15","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","volume":"106","author":"V McLaughlin","year":"2002","unstructured":"McLaughlin V, Shillington A, Rich S: Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation. 2002, 106 (12): 1477-1482. 10.1161\/01.CIR.0000029100.82385.58.","journal-title":"Circulation"},{"issue":"2","key":"288_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","volume":"122","author":"M Humbert","year":"2010","unstructured":"Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Ya\u00efci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubet M, Haloun A, Lautent M, Hachulla E, Cottin V, Degano B, Jais X, Montani D, Souza R, Simonneau G: Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010, 122 (2): 156-163. 10.1161\/CIRCULATIONAHA.109.911818.","journal-title":"Circulation"},{"issue":"5","key":"288_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/eurheartj\/ehi728","volume":"27","author":"S Provencher","year":"2006","unstructured":"Provencher S, Sitbon O, Humbert M, Cabrol S, Ja\u00efs X, Simonneau G: Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. Eur Heart J. 2006, 27 (5): 589-595. 10.1093\/eurheartj\/ehi728.","journal-title":"Eur Heart J"},{"issue":"3","key":"288_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.healun.2008.12.003","volume":"28","author":"W Jacobs","year":"2009","unstructured":"Jacobs W, Boonstra A, Marcus J, Postmus P, Vonk-Noordegraaf A: Addition of prostanoids in pulmonary hypertension deteriorating on oral therapy. J Heart Lung Transplant. 2009, 28 (3): 280-284. 10.1016\/j.healun.2008.12.003.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"288_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1445-5994.2010.02333.x","volume":"41","author":"M Salamonsen","year":"2011","unstructured":"Salamonsen M, Keating D, Whitford H, Bailey M, Miller T, Manterfield C, Williams T: IVI epoprostenol as salvage therapy in pulmonary arterial hypertension: an Australian perspective. Intern Med J. 2011, 41 (3): 245-251. 10.1111\/j.1445-5994.2010.02333.x.","journal-title":"Intern Med J"},{"issue":"1","key":"288_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.rmed.2009.07.015","volume":"104","author":"KK Mubarak","year":"2010","unstructured":"Mubarak KK: A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension. Respir Med. 2010, 104 (1): 9-21. 10.1016\/j.rmed.2009.07.015.","journal-title":"Respir Med"},{"issue":"2","key":"288_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/hrt.79.2.175","volume":"79","author":"T Higenbottam","year":"1998","unstructured":"Higenbottam T, Butt A, Dinh-Xaun A, Takao M, Cremona G, Akamine S: Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost. Heart. 1998, 79 (2): 175-179.","journal-title":"Heart"},{"issue":"2","key":"288_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/hrt.80.2.151","volume":"80","author":"T Higenbottam","year":"1998","unstructured":"Higenbottam T, Butt A, McMahon A, Westerbeck R, Sharples L: Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension. Heart. 1998, 80 (2): 151-155.","journal-title":"Heart"},{"issue":"1","key":"288_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1378\/chest.126.1.90","volume":"126","author":"R Oudiz","year":"2004","unstructured":"Oudiz R, Widlitz A, Beckmann X, Camanga D, Alfie J, Brundage B, Barst R: Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension. Chest. 2004, 126 (1): 90-94. 10.1378\/chest.126.1.90.","journal-title":"Chest"},{"issue":"4","key":"288_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1086\/529552","volume":"29","author":"A Kallen","year":"2008","unstructured":"Kallen A, Lederman E, Balaji A, Trevino I, Petersen E, Shoulson R, Saiman L, Horn E, Gomberg-Maitland M, Barst R, Srinivasan A: Bloodstream infections in patients given treatment with intravenous prostanoids. Infect Control Hosp Epidemiol. 2008, 29 (4): 342-349. 10.1086\/529552.","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2466-11-56\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-11-56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-11-56","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-11-56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T17:03:45Z","timestamp":1548090225000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/1471-2466-11-56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1186\/1471-2466-11-56","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"article-number":"56"}}